Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alane Izu

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Eclinicalmedicine|July 10, 2023
Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant dataShuo Feng, Julie McLellan, Nicola Pidduck, et al.
Health Technology Assessment (Winchester, England)|July 24, 2024
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysisShuo Feng, Julie McLellan, Nicola Pidduck, et al.
Vaccine|July 2, 2022
Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021Peter B Gilbert, Richard Isbrucker, Nick Andrews, et al.
Viruses|February 28, 2023
Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-Length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19Muneerah Smith, Gaurav Kwatra, Alane Izu, et al.
Vaccine|February 3, 2024
Obstetric and neonatal outcomes in South AfricaClare L Cutland, Shobna Sawry, Lee Fairlie, et al.
The Lancet. Infectious Diseases|August 29, 2020
Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trialShabir A Madhi, Eleonora Aml Mutsaerts, Alane Izu, et al.
The Lancet. Child & Adolescent Health|March 19, 2023
Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trialCourtney P Olwagen, Alane Izu, Eleonora A M L Mutsaerts, et al.
AIDS (London, England)|December 8, 2022
T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South AfricaWilliam C McMahon, Gaurav Kwatra, Alane Izu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
An Observational Pilot Study Evaluating the Utility of Minimally Invasive Tissue Sampling to Determine the Cause of Stillbirths in South African WomenShabir A Madhi, Jayani Pathirana, Vicky Baillie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Unraveling Specific Causes of Neonatal Mortality Using Minimally Invasive Tissue Sampling: An Observational StudyShabir A Madhi, Jayani Pathirana, Vicky Baillie, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Eclinicalmedicine|July 10, 2023
Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant dataShuo Feng, Julie McLellan, Nicola Pidduck, et al.
Health Technology Assessment (Winchester, England)|July 24, 2024
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysisShuo Feng, Julie McLellan, Nicola Pidduck, et al.
Vaccine|July 2, 2022
Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021Peter B Gilbert, Richard Isbrucker, Nick Andrews, et al.
Viruses|February 28, 2023
Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-Length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19Muneerah Smith, Gaurav Kwatra, Alane Izu, et al.
Vaccine|February 3, 2024
Obstetric and neonatal outcomes in South AfricaClare L Cutland, Shobna Sawry, Lee Fairlie, et al.
The Lancet. Infectious Diseases|August 29, 2020
Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trialShabir A Madhi, Eleonora Aml Mutsaerts, Alane Izu, et al.
The Lancet. Child & Adolescent Health|March 19, 2023
Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trialCourtney P Olwagen, Alane Izu, Eleonora A M L Mutsaerts, et al.
AIDS (London, England)|December 8, 2022
T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South AfricaWilliam C McMahon, Gaurav Kwatra, Alane Izu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
An Observational Pilot Study Evaluating the Utility of Minimally Invasive Tissue Sampling to Determine the Cause of Stillbirths in South African WomenShabir A Madhi, Jayani Pathirana, Vicky Baillie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Unraveling Specific Causes of Neonatal Mortality Using Minimally Invasive Tissue Sampling: An Observational StudyShabir A Madhi, Jayani Pathirana, Vicky Baillie, et al.
Pageof 8